This thesisd escribess yntheticw ork carriedo ut on two separatep rojects. (i) Synthetics tudiest owardst he total synthesiso f galanthamine (ii) The total synthesis of 2-Benzoyl-9-azabicyclo[4.2.1 ]non-2-ene Galanthamine is an amaryllidaceae alkaloid processing a rigid tetracyclic structure with a fused dihydrobenzofuran onto a cyclohexenol and a bridging tertiary amine. 2-Benzoyl-9-azabicyclo[4.2.1]non-2-ene is an analogue of anatoxin-a, whereby the acetyl side chain has been substituted with a benzoyl group. Anatoxin-a itself possesses a 9-azabicyclo[4.2.1]nonane framework. Although structurally very different they both share a common feature in that they interact with acetylcholine receptors. Hence chapter 1 is an introduction to Alzheimer's disease which is primarily caused by a lack of acetylcholine. A literature review of the total syntheses of galanthamine and a background of galanthamine is described in chapter 2, whilst chapter 3 details the forward synthesis to the galanthamine framework but with a cyclopentenyl instead of a cyclohexenyl moiety and subsequent attempts for the elaboration of the cyclopentenyl into its corresponding cyclohexenyl moiety. Chapter 4 and 5 describes the published total syntheses of anatoxin-a and analogues of anatoxin-a, whilst chapter 6 concludes the total synthesis of the phenyl analogue of anatoxin-a via a key selenium mediated transannular cyclisation of a Boc-(3-Lactam to furnish the 9-azabicyclo[4.2. l]nonane ring system.

No description available.

La synthèse de la 5-azagalanthamine, un analogue azoté de galanthamine, utilisée dans le traitement palliatif de la maladie d’Alzheimer, a été envisagée dans le cadre d’une étude de relations structure-activité. Durant cette thèse nous avons examiné quatre voies de synthèse afin d’accéder à la 5-azagalanthamine. La première voie est basée sur la réaction de Pictet-Spengler afin de fermer le dernier cycle de l’azagalanthamine. De nombreuses tentatives ont été effectuées sur différents types de substrats mais cette stratégie s’est révélée inefficace. La deuxième approche consiste en une oxydation d’anilide ortho-substitué par un groupement méthoxy, avec un réactif à base d'iode hypervalent pour accéder à une spirodiènone, un intermédiaire clé de la synthèse. En effectuant cette réaction nous n’avons pas obtenu le produit attendu, mais une 1,2-dispirodiénone, un motif inhabituel, et très rare. Après avoir optimisé les conditions réactionnelles, nous avons étudié la généralité de la réaction avec d'autres substrats. La modélisation moléculaire ainsi que des études de voltammétrie cyclique ont été réalisées (Chabaud, L.; Hromjakova, T.; Rambla, M.; Retailleau, P.; Guillou, C. Chem. Commun. 2013, 49, 11542-11544. Hromjakova, T.; Retailleau, P.; Grimaud, L.; Gandon, V.; Chabaud, L. et Guillou, C. accepté EurJOC, 2015, DOI 10.1002/ejoc.201501160).Ensuite nous avons examiné l’approche basée sur le couplage intramoléculaire pallado-catalysé. Après les premiers résultats encourageant avec le substrat modèle nous avons réalisé une optimisation des conditions réactionnelles. Une étude de généralité de la réaction avec d'autres substrats a été effectuée. Malheureusement, il s’est avéré que la substitution sur le cycle aromatique n’était pas bien tolérée conduisant à de faibles rendements. Par conséquent cette méthodologie n’a pas pu être appliquée à la synthèse de l’azagalanthamine. Dans la dernière voie de synthèse examinée nous avons repris les travaux antérieurs entrepris dans notre laboratoire concernant la réaction de Heck intramoléculaire. La diminution de la longueur de la chaîne liant les deux cycles a permis d’obtenir des résultats très prometteurs. / The synthesis of 5-azagalanthamine, the analogue of galanthamine that is used in Alzheimer treatment, was investigated for structure - activity relationship studies.During this thesis I explored four synthetic approaches with the aim of preparing the 5-azagalanthamine. The first one is based on a Pictet-Spengler reaction used for ring closure of the last cycle of azagalanthamine. We carried out many tests on various types of substrate but this strategy has proved to be ineffective. The second approach consists of an oxidation of ortho-methoxy substituted anilide by hypervalent iodine reagent to access a spirodienone, a key intermediate of the synthesis. Interestingly this reaction did not result in the expected compound but we observed the formation of an unusual motif, the 1,2-dispirodienone. After conditions optimisation we studied the scope and limitations with others substrates. Molecular modelling and cyclic voltammetry studies were also carried out (Chabaud, L.; Hromjakova, T.; Rambla, M.; Retailleau, P.; Guillou, C. Chem. Commun. 2013, 49, 11542-11544. Hromjakova, T.; Retailleau, P.; Grimaud, L.; Gandon, V.; Chabaud, L. and Guillou, C. accepté EurJOC, 2015, DOI 10.1002/ejoc.201501160).Then we investigated an approach based on palladium-catalysed intramolecular coupling. After the first encouraging results with the model substrate, we did optimization of the reaction conditions and the study of substrate scope. Unfortunately we discovered that the substitution was not well tolerated and decreased the yield. Therefore this methodology could not be applied to the synthesis of the azagalanthamine. In the last approach we used previous work of our laboratory on the intramolecular Heck reaction. The reduction of the length of the linker between both cycles showed to be beneficial. We obtained promising results with this approach.

The previously described 2-aryl-4-chloro-3-iodoquinolines were prepared following literature procedure and in turn converted to the corresponding hitherto unknown 2-aryl-3-iodo-4-(phenylamino)quinoline derivatives using aniline in refluxing ethanol. These 2-aryl-3-iodo-4-(phenylamino)quinolines were reacted with allybromide in ethanol at room temperature to afford 4-(N,N-allylphenylamino)-2-aryl-3-iodoquinoline derivatives. The 2-aryl-3-iodo-4-(phenylamino)quinoline and 4-(N,N-allylphenylamino)-2-aryl-3-iodoquinoline derivatives were subjected to metal-catalysed carbon-carbon bond formations. Palladium(0)-copper iodide catalysed Sonogashira cross-coupling of 2-aryl-3-iodo-4-(phenylamino)quinoline with terminal alkynes afforded series of 1,2,4-trisubstituted 1H-pyrrolo[3,2-c]quinolines in a single step operation. On the other hand, the 4-(N,N-allylphenylamino)-2-aryl-3-iodoquinoline derivatives were found to undergo palladium-catalysed intramolecular Heck reaction to yield the corresponding 1,3,4-trisubstituted 1H-pyrrolo[3,2-c]quinolines. All new compounds were characterized by using a combination of NMR (1H and 13C), IR, mass spectroscopic techniques as well as elemental analysis. / Chemistry / MSc. (Chemistry)

The previously described 2-aryl-4-chloro-3-iodoquinolines were prepared following literature procedure and in turn converted to the corresponding hitherto unknown 2-aryl-3-iodo-4-(phenylamino)quinoline derivatives using aniline in refluxing ethanol. These 2-aryl-3-iodo-4-(phenylamino)quinolines were reacted with allybromide in ethanol at room temperature to afford 4-(N,N-allylphenylamino)-2-aryl-3-iodoquinoline derivatives. The 2-aryl-3-iodo-4-(phenylamino)quinoline and 4-(N,N-allylphenylamino)-2-aryl-3-iodoquinoline derivatives were subjected to metal-catalysed carbon-carbon bond formations. Palladium(0)-copper iodide catalysed Sonogashira cross-coupling of 2-aryl-3-iodo-4-(phenylamino)quinoline with terminal alkynes afforded series of 1,2,4-trisubstituted 1H-pyrrolo[3,2-c]quinolines in a single step operation. On the other hand, the 4-(N,N-allylphenylamino)-2-aryl-3-iodoquinoline derivatives were found to undergo palladium-catalysed intramolecular Heck reaction to yield the corresponding 1,3,4-trisubstituted 1H-pyrrolo[3,2-c]quinolines. All new compounds were characterized by using a combination of NMR (1H and 13C), IR, mass spectroscopic techniques as well as elemental analysis. / Chemistry / MSc. (Chemistry)